Stock Ratings / Financials / NHI / dividends

BNL (56) HIW (70) IRT (62) CXW (56) ⌘ Pro Terminal →

National Health Investors Inc. (NHI) Dividend Safety Gauge & 10-Year DRIP Compounder

$66.95 +1.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $67.06

National Health Investors Inc. (NHI) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $3.29B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NHI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, National Health Investors Inc. (NYSE: NHI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $66.95 (+1.93% 1D, market cap $3.29B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 8/20. Across 1096 tracked Financials issuers, NHI ranks #888 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does NHI compare to BNL and HIW in the Financials sector?

▼

Within the Financials sector (Real Estate Investment Trusts), NHI carries a Roarable D (48/100 RQD), trailing P/E of 23.1x, gross margin of —, and ROIC of 9.3%. By comparison, BNL (Broadstone Net Lease Inc.) holds a D+ grade (56/100 RQD, P/E 34.6x, ROIC 2.3%, cap $3.34B) and HIW (Highwoods Properties Inc.) posts a B- grade (70/100 RQD, P/E N/A, ROIC 18.3%, cap $3.36B). Among the 5-stock peer group, NHI leads on earnings multiple (23.1x) while HIW leads on capital efficiency (18.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NHI?

▼

Per NHI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000877860), National Health Investors Inc. generated $80.1M in revenue (+47.1% YoY), $142.2M in net income, and -$57.5M in free cash flow against $2.80B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $67.06 (+0.16%)🧬 Disciplined Float (+1.08% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-4.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NHI)Realized 20D OHLCV Swing Band: ±4.4%

Deterministic 5-Pillar Attribution (48/100 Composite)

🔍 WHY NHI SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (21% of score)

20D Institutional Volume Accumulation (±4.4% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution8/20 pts (-12 pt drag)

Disciplined Float (+1.08% YoY Shares) & executive Form 4 sales trim 12 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$64.85+2.2% Next Q

Q2 (-2Q)

Grade D$66.28+1.2% Next Q

Q3 (-1Q)

Grade D$67.06-0.2% Next Q

Current

Grade D$66.95-5.6% Hist 90D α

Trajectory: D (40) → D (48)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NHI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NHI currently carries a cautious 48/100 (D) rating due to Insider Conviction & Share Dilution (8/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($68.10) and Max Pain ($70.30) forces dealer call-delta covering toward $95.95.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+1.08% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NHI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NHI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 48%NO 52%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

5.76% Total Yield

5.16% Cash ($3.45/yr) + 0.6% Buybacks

PAYOUT SAFETY SPEEDOMETER

41/100 • ELEVATED PAYOUT WATCH

FREE CASH FLOW PAYOUT RATIO

96% of FCF

8 consecutive years of payout growth

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (20.3% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $63,483

Est. Year-10 Shareholder Yield: $3,657/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$12.0K

Yr 1

$14.5K

Yr 2

$17.4K

Yr 3

$20.9K

Yr 4

$25.2K

Yr 5

$30.3K

Yr 6

$36.5K

Yr 7

$43.9K

Yr 8

$52.8K

Yr 9

$63.5K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NHI)

✓Walkthrough of NHI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NHI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.95%📐 HORIZONTAL RANGE

2026-10-30O $67.57H $67.80L $66.90C $66.95VOL 269.4K

RES: $87.55SUP: $61.18SMA50: $68.10SMA200: $76.38

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NHI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NHI Butterfly Map → + Track NHI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

16.9%/yr Implied 5Y Growth

vs. +47.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NHI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NHI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NHI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHI)

Financials Rank #888 of 1096 ⚔️ BNL vs NHI Full Matrix →

1. Head-to-Head Financials Peer Comparison (NHI vs. BNL, HIW, IRT, CXW)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, National Health Investors Inc. (NHI) ranks #888 by composite RQD confidence (48/100, grade D) and #345 by equity capitalization ($3.29B). Within this direct 5-issuer industry benchmark cohort, NHI leads on earnings valuation at 23.1x trailing P/E, while HIW leads on capital efficiency and profitability with 18.3% ROIC and — gross margin. HIW currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with NHI at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NHI ACTIVE National Health Investors Inc.	D	48/100	23.1x	—	9.3%	+1.93%	$3.29B	Benchmark Subject
BNL Broadstone Net Lease Inc.	D+	56/100	34.6x	—	2.3%	+3.20%	$3.34B	/bnl-vs-nhi →
HIW Highwoods Properties Inc.	B-	70/100	—	—	18.3%	+4.42%	$3.36B	/hiw-vs-nhi →
IRT Independence Realty Trust Inc.	C	62/100	61.7x	—	1.6%	+2.42%	$3.49B	/irt-vs-nhi →
CXW CoreCivic Inc.	D+	56/100	—	—	—	+1.47%	$3.07B	/cxw-vs-nhi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000877860

In its most recent audited fiscal period (FY2025, filed 2025-12-31), National Health Investors Inc. (NHI) reported GAAP revenue of $80.1M (+47.1% vs. FY2024 revenue of $54.4M , and +64.0% cumulative change since FY2023) , GAAP net income of $142.2M, operating cash flow of $236.6M, and free cash flow of -$57.5M (-215.3% YoY). On the balance sheet, NHI closed FY2025 with $2.80B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$80.1M	$142.2M	$236.6M	-$57.5M	$2.80B	—
FY2024 (FY)	2024-12-31	$54.4M	$138.0M	$207.8M	$49.8M	$2.61B	—
FY2023 (FY)	2023-12-31	$48.8M	$135.7M	$184.4M	$184.4M	—	—

3. NHI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does NHI compare to BNL and HIW in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for NHI?

Where is NHI trading relative to its 50-day, 200-day, and 52-week technical levels?

NHI last traded at $66.95 (+1.93% on volume of 182,947 shares), positioning the stock -1.69% below its 50-day simple moving average ($68.10) and -12.35% below its 200-day simple moving average ($76.38). Across its 52-week range of $63.51 to $91.38, NHI sits at the 12.3% percentile with a 14-day RSI of 51.6 (NEUTRAL RANGE) and an implied next-earnings move of ±4.4% ($64.00 to $69.90).

NHI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does NHI pay a dividend and is it safe?

National Health Investors Inc. (NHI) offers a 5.16% cash dividend yield ($3.45 annualized) and 5.76% total shareholder yield including buybacks. Roarable rates its payout coverage as ELEVATED PAYOUT WATCH.

Direct Sub-Reports: NHI RQD Cockpit NHI 12M Forecast NHI Earnings & Move NHI Dividends & DRIP NHI Insiders & 13F NHI Whale Options NHI Profit Sankey NHI News & Why